Tag: Advanced RCC (Renal Cell Carcinoma)

news-22072024-204234

Limited Benefit of Nivolumab/Tivozanib in Advanced RCC Post-Immunotherapy

The combination of nivolumab and tivozanib did not show an improvement in progression-free survival (PFS) for patients with advanced metastatic renal cell carcinoma (RCC)...